Alivus Life Sciences Limited
Government Pension Fund Global (Norway) cut its stake in Alivus Life Sciences from 2.40% to 2.33%, selling 85,000 shares.
A specialized pharmaceutical manufacturer focused on developing and producing high-value active pharmaceutical ingredients for chronic disease treatments across multiple therapeutic areas. Operating as a subsidiary of Nirma Limited, a diversified conglomerate, the company serves global specialty pharmaceutical companies through contract development and manufacturing services. Its distinctive strength lies in producing non-commoditized APIs where technical expertise, regulatory compliance, and quality standards are paramount.
Norway's sovereign wealth fund, managed by Norges Bank Investment Management. World's largest SWF with over USD 2 trillion in assets, invested across 8,700+ companies globally including Indian equities.